Suchergebnisse - "Dexamethasone"

PubPharm (140.403)

51

Small RNA Sequencing Reveals a Distinct MicroRNA Signature between Glucocorticoid Responder and Glucocorticoid Non-responder Primary Human Trabecular Meshwork Cells after Dexamethasone Treatment

enthalten in: bioRxiv.org | 2024

von Kathirvel, K. | Fan, X. | Haribalaganesh, R. | +6

52

Protocol for a multicentre randomised controlled trial of STeroid Administration Routes For Idiopathic Sudden sensorineural Hearing loss: the STARFISH trial

enthalten in: bioRxiv.org | 2024

von Smith, M. | Knappet, R. | Vickers, D. | +11

53

Arabidopsis CML13 and CML14 Have Essential And Overlapping Roles In Plant Development

enthalten in: bioRxiv.org | 2024

von Symonds, K. | Teresinski, H. | Hau, B. | +2

54

The glucocorticoid dexamethasone inhibits HIF-1alpha stabilisation and metabolic reprogramming in lipopolysaccharide-stimulated primary macrophages

enthalten in: bioRxiv.org | 2024

von Clayton, S. | Lockwood, C. | O’Neil, J. | +6

55

Activation of glucocorticoid receptor signaling inhibits KSHV-induced inflammation and tumorigenesis

enthalten in: bioRxiv.org | 2024

von Chen, L. | Ding, L. | Wang, X. | +2

56

Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone

enthalten in: bioRxiv.org | 2024

von Nadeem, O. | Aranha, M. | Redd, R. | +19

57

A Study to Determine Dose, Safety, Tolerability, Drug Levels, and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Participants With Multiple Myeloma : A Phase 1b/2a Multicenter, Open-label, Dose-escalation Study to Determine the Maximum Tolerated Dose, Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CC-220 as Monotherapy and in Combination With Other Treatments in Subjects With Multiple Myeloma

enthalten in: ClinicalTrials.gov | 2024

58

Dexamethasone in Controlling Dyspnea in Patients With Cancer : A Randomized Controlled Trial of Dexamethasone for Dyspnea in Cancer Patients

enthalten in: ClinicalTrials.gov | 2024

59

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy : A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy

enthalten in: ClinicalTrials.gov | 2024

60

Steroids After Spine Fusion Surgery : Postoperative Steroids and Recovery After Spine Fusion

enthalten in: ClinicalTrials.gov | 2024